Sir, We read with great interest the review by Cholo et al. 1 regarding the mechanisms of action and therapeutic efficacies of clofazimine and bedaquiline. We would like to submit further views on the genetic basis of clofazimine resistance in Mycobacterium tuberculosis. rv0678 is clearly a very important genetic locus involved in such resistance, as it is found in both laboratoryselected and clinically isolated mutants of M. tuberculosis. [2] [3] [4] [5] In recent years, mutations in rv1979c and rv2535c have also been reported to be associated with resistance of M. tuberculosis to the riminophenazines. 4 ,5 BLASTP 6 was used to search homologous proteins with more than 40% identities and 90% query coverage for Rv0678, Rv1979c and Rv2535c. Since the functional similarity between homologous proteins is less predictable, we decided to infer functional similarity by orthologues. 7 Detailed results are shown in Table 1 . Rv0678 is well known as a transcriptional repressor that binds to a sequence located in the intergenic region between this gene locus and the neighbouring mmpS5 and mmpL5 genes. 2 The MmpL protein family has the putative function of transporting lipids, and a significant proportion of these membrane proteins are conserved within the genome of Mycobacterium leprae. These mycobacterial proteins apparently have contributory roles in the virulence and drug resistance of the pathogens. While the absence of the rv0678-mmpS5-mmpL5 locus (the mutation of which is associated with up-regulation of the multisubstrate efflux pump leading to drug resistance) in M. leprae is rather intriguing, 2 orthologues of Rv0678 are found in Mycobacterium bovis as Mb0697, and Mycobacterium marinum as MMAR_1007. Furthermore, the orthologues of Rv1979c and Rv2535c in M. tuberculosis are found in the genome of M. leprae, as ML1974 and ML0521, respectively. Another orthologue of Rv1979c is Mb2001c (in M. bovis), but it is absent in Bacillus Calmette-Guérin (BCG) due to deletion and its role in altering clofazimine susceptibility in BCG is thus unknown. The molecular function of Rv1979c is believed to be that of amino acid transmembrane transporter with permease activity. 4 Although the molecular function of Rv2535c has not been fully characterized, it is likely to be that of a peptidase. 4 Orthologues of Rv2535c include Mb2564c (in M. bovis) and MMAR_2180 (in M. marinum). In the absence of Rv0678 homologues in M. leprae, we hypothesize that mutations in rv1979c and rv2535c orthologues of M. leprae may have causative roles in clofazimine resistance in this organism. Contrary to what is generally assumed, clofazimine resistance in M. leprae has been reported, though details of the underlying molecular mechanisms are lacking. 8 Prolonged duration of treatment with clofazimine, especially on a highly intermittent basis, say once monthly (as per WHO guidelines on treatment of multibacillary leprosy), may increase the propensity for resistance in M. leprae to this riminophenazine. If a patient with leprosy also has latent infection or subclinical disease due to M. tuberculosis, it would not be hard to envisage the possible development of dual bacillary resistance in both mycobacterial species, following clofazimine treatment for the former disease, with involvement of very similar molecular mechanisms. Such a scenario may explain, at least partially, primary clofazimine resistance in M. tuberculosis. Although clofazimine is not commonly included in the regimens for treatment of non-tuberculous mycobacterial infections, it sometimes finds a place for such treatment under specific settings, with the attendant risk of development of mycobacterial resistance. In addition, while horizontal transfer of genetic materials between M. leprae and M. tuberculosis has not been reported, such a possibility cannot be totally excluded in other mycobacteria, as suggested by the recent findings regarding genomic islands that display a wide spectrum of genes, including those annotated as phagic or plasmid genes, in clinical and environmental Mycobacterium avium subsp. hominissuis. 9 The relevance of these observations for clofazimine resistance in mycobacterial species appears elusive at present; however, future research is warranted for better delineation.
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None to declare. Sir, Multiply, extensively and pan resistant isolates of Acinetobacter baumannii are predominantly members of two globally distributed clones, GC1 and GC2. By the mid to late 1970s, these clones had acquired resistance to the antibiotics in use at the time, and the resistance genes were subsequently found to be located in resistance islands in the chromosome, an AbaR-type island in the GC1 clone, and AbGRI1-type and AbGRI2-type islands in GC2 isolates. These islands are present in the earliest GC1 and GC2 isolates still available for study. [1] [2] [3] The AbaR and AbGRI1 islands are both located in the comM gene, as they are each complex class III transposons with a set of tniC-tniA-tniB-tniD-tniE transposition genes that target this location. The resistance genes in AbaR and AbGRI2 islands were recently found to originate from a complex resistance gene cluster in the IncM1 plasmid R1215. 4 Here, we have explored the origin of the AbGRI1 island.
Various forms of the AbGRI1-type island have been found [5] [6] [7] [8] and each can be derived from a common ancestor with a structure resembling that shown in Figure 1(a) . The wide variety of other forms seen to date can be derived from AbGRI1-0 via addition or loss of additional segments or transposons. For example, a deletion within Tn6022 gives rise to the commonly detected deletion derivative Tn6022D, or the tet(B) determinant can be added in via homologous recombination between CR2 in the AbGRI1 and a partial copy of CR2 adjacent to the tet(B) determinant. These two events give rise to AbGRI1-Var (Figure 1a ). Subsequent introduction of Tn6022 into the extreme end of the tetA(B) gene provides a third tni transposon 8 and deletions via homologous recombination between the tni genes in this transposon and one of the transposons, Tn6022 or Tn6022D, found at the left end can cause loss of the central segment and the sul2 gene to give rise to the simpler structure seen in AbGRI1-1 (Tn6166) in A320. 5 The Tn6022 copies can acquire the oxa23 carbapenem resistance transposon Tn2006 to form AbaR4 (Tn6022::Tn2006) and additional antibiotic resistance
